S100A7 and breast cancer: Anyway, our data nicely fit with previous investigations showing that in MCF-7 and T47D BC cells, inflammatory cytokines like Oncostatin-M and IL-6 prompt the increase of S100A7 through the involvement of ERK1/2, PI3K/AKT and STAT3 signaling pathways [27].